Fig 1.
The algorithm for the selection of eligible cases of DF in this study.
IHC, immunohistochemistry.
Fig 2.
Immunohistochemical staining for β-catenin and identification of CTNNB1 gene mutation.
A, Cytoplasmic expression of β-catenin (negative). B, Nuclear expression of β-catenin (positive). C, CTNNB1 gene mutation in exon3 codon 41 (121A>G, T41A; 122C>T, T41I) and codon 45 (133T>C, S45P; 134C>T, S45F). Scale bar, 50μm.
Table 1.
Clinicopathological parameters in desmoid-type fibromatosis patients.
Table 2.
Clinicopathological findings in desmoid-type fibromatosis patients according to CTNNB1 mutation status.
Table 3.
β-catenin expression and CTNNB1 mutation status in desmoid-type fibromatosis patients according to specimen types.
Table 4.
Mutation types of the CTNNB1 gene.
Table 5.
Clinicopathological findings in desmoid-type fibromatosis patients according to CTNNB1 mutation types.